WELCOME to the EMORY WOMEN’S MENTAL HEALTH PROGRAM |
|
|
Our website will provide you straightforward information regarding safe and effective treatment of mental illness in women with an emphasis on pregnancy, the postpartum period, and breast-feeding. |
|
|
You'll find a presentation of the clinical services and research studies offered by our program in addition to down-to-earth discussions of recent research findings and what those findings mean for your care. |
|
WMHP PUBLICATIONS - Most Recent Article
Maternal depression and anxiety differentially impact fetal exposures during pregnancy.
OBJECTIVE: To examine the association between severity of maternal depression and anxiety during pregnancy and the maternal use of medicinal agents and habit-forming substances.
RESULTS: Among 195 participants, both HDRS AUC and HARS AUC were negatively correlated with prenatal vitamin exposure (r = -0.22 [P = .002] and r = -0.26 [P = .0003], respectively) and positively correlated with tobacco (r = 0.21 [P = .003] and r = 0.20 [P = .006], respectively) and hypnotic (r = 0.28 [P < .0001] and r = 0.19 [P = .008], respectively) exposure. . . .
WMHP BLOG - Most Recent Entries
Hale's Breastfeeding Safety Ratings: Part 5 - Anxiolytics & Benzodiazepines
In this entry in the series, we summarize Dr. Hale's findings regarding the safety of Anxiolytics & Benzodiazepines during breastfeeding.
Hale's Breastfeeding Safety Ratings: Part 4 - Stimulants
In this entry in the series, we summarize Dr. Hale's findings regarding the safety of Stimulants & Attention Deficit Disorder Medications during breastfeeding.